O

Oblita Therapeutics (Private limited company)

OBLITA THERAPEUTICS
BE 0832.102.424 Active ●Oostmallebaan 87, 2980 Zoersel

Oblita Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0832.102.424. It was founded on 20-12-2010. Its registered office is in Zoersel. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 33 262 and a loss of € 13 569. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 21-10-2026.

Company information

Status
Active
Enterprise number
BE 0832.102.424
VAT registered
Yes
Founded
20-12-2010
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Oostmallebaan 87, 2980 Zoersel
Main activity
Scientific research and development
NACE activities
72101 Recherche-développement en biotechnologie
10860 Fabrication d’aliments homogénéisés et diététiques
10890 Fabrication d’autres produits alimentaires nca
21100 Fabrication de produits pharmaceutiques de base
21201 Fabrication de médicaments
46389 Commerce de gros d'autres produits alimentaires nca
46442 Commerce de gros de produits d'entretien
46460 Commerce de gros de produits pharmaceutiques et médicaux
47783 Commerce de détail d'articles de droguerie et de produits d'entretien
64210 Activités de société holding
72109 Recherche-développement en autres sciences physiques et naturelles
73110 Activités d’agence de publicité
73200 Études de marché et sondages
82300 Organisation de salons professionnels et congrès
82990 Autres activités de service de soutien aux entreprises nca

Key figures of Oblita Therapeutics

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -13 569+80 %€ -68 701-179 %€ -24 638€ 20 628
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 33 262-77 %€ 145 944-32 %€ 214 644+62 %€ 132 158
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 418 521-17 %€ 502 246+12 %€ 449 019+27 %€ 354 835
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 112 473€ -15 244+32 %€ -22 510€ 22 237
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Zoersel.

CompanyTown
AVIA-GIS 2980 Zoersel
Escaperoomantwerp 2980 Zoersel
CeeMCee Pharma Consulting 2980 Zoersel
Studiebureau ENERGEOS 2980 Zoersel
Blue3Berg 2980 Zoersel
EDF Quality Services 2980 Zoersel
SHANA TIELEMANS 2980 Zoersel
ASCIA 2980 Zoersel
Looking for more information about Oblita Therapeutics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Oblita Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Oblita Therapeutics as active.

What is the VAT number of Oblita Therapeutics? The VAT number of Oblita Therapeutics is BE 0832.102.424.

When was Oblita Therapeutics founded? Oblita Therapeutics was founded on 20-12-2010.

What is the address of Oblita Therapeutics? The current registered office of Oblita Therapeutics is Oostmallebaan 87, 2980 Zoersel.

When did Oblita Therapeutics last file annual accounts? The latest annual accounts of Oblita Therapeutics were filed on 28-08-2026.

Does Oblita Therapeutics file its annual accounts on time? Oblita Therapeutics filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2022.

Is Oblita Therapeutics financially healthy? Addrly gives Oblita Therapeutics a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Oblita Therapeutics profitable? The annual accounts of Oblita Therapeutics for 2025 show a loss of € 13 569.

What is the equity of Oblita Therapeutics? The equity of Oblita Therapeutics was € 33 262 at the close of the 2025 financial year.

Who are the directors of Oblita Therapeutics? The annual accounts of Oblita Therapeutics record 1 mandate. The name, role and dates are visible with a free account.

Can Oblita Therapeutics receive Peppol e-invoices? Yes. Oblita Therapeutics is registered on the Peppol network and can receive structured electronic invoices.

What does Oblita Therapeutics do? The main activity of Oblita Therapeutics is: Scientific research and development.

Sources

How Addrly builds and refreshes this data